Growth Hormone Therapy in Pediatrics PDF
By:Michael B. Ranke,David Anthony Price,Edward O. Reiter
Published on 2007-01-01 by Karger Medical and Scientific Publishers
For 20 years, KIGS (Pfizer International Growth Database) has provided an outstanding tool for monitoring the use, efficacy and safety of growth hormone (GH) treatment in children with short stature of varying origin. This volume offers a comprehensive update of the continuing experiences in KIGS and is based on data from more than 50 countries and more than 60,000 patients. International experts analyse in detail the basic auxological characteristics of patients and their response to GH treatment for a broad spectrum of growth disorders. These include idiopathic GH deficiency, organic GH deficiency due to a variety of causes such as congenital malformations and syndromes, genetic disorders or treatment for leukaemia or central nervous system tumours and short stature in children born small for gestational age, specific syndromes and systemic disorders. Each growth disorder is also covered by a review of relevant published data by international experts. KIGS has also established itself as a primary source of information about adverse events during long-term GH treatment in children. The recent analysis of KIGS data has revealed no new adverse drug reactions since the 10-year follow-up. Therefore, treatment with GH seems a low-risk intervention in children and adolescents with various growth disorders. The process of developing disease-specific growth response prediction models has been ongoing in KIGS for many years. The available models are accurate, precise and have a relatively high degree of predictive power, although further predictors of the growth response remain to be identified. The KIGS prediction models can be applied prospectively to new patients, enabling their GH therapy to be better tailored and monitored to achieve optimal growth, safety and cost outcomes. The future of KIGS within the era of evidence-based medicine will continue to depend upon the quality of the data reported. Therefore, the commitment of participating physicians will continue to be a decisive element. The ongoing recognition of the importance of valid safety and efficacy information in the practice of paediatric endocrinology is exemplified by this valuable international collaboration of clinicians and the pharmaceutical community.
This Book was ranked at 19 by Google Books for keyword Pediatrics.
Book ID of Growth Hormone Therapy in Pediatrics's Books is 0aW5cIGr7ZEC, Book which was written byMichael B. Ranke,David Anthony Price,Edward O. Reiterhave ETAG "e8Fg82OQxqw"
Book which was published by Karger Medical and Scientific Publishers since 2007-01-01 have ISBNs, ISBN 13 Code is 9783805582568 and ISBN 10 Code is 3805582560
Reading Mode in Text Status is false and Reading Mode in Image Status is true
Book which have "519 Pages" is Printed at BOOK under CategoryMedical
Book was written in en
eBook Version Availability Status at PDF is falseand in ePub is false
Book Preview
Download Growth Hormone Therapy in Pediatrics PDF Free
Download Growth Hormone Therapy in Pediatrics Books Free
Download Growth Hormone Therapy in Pediatrics Free
Download Growth Hormone Therapy in Pediatrics PDF
Download Growth Hormone Therapy in Pediatrics Books
Tidak ada komentar:
Posting Komentar